Wellington Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$86.6M Buy
458,014
+345,454
+307% +$60.4M 0.02% 583
2025
Q4
$19.1M Sell
112,560
-16,639
-13% -$2.55M ﹤0.01% 1049
2025
Q3
$17M Buy
129,199
+9,814
+8% +$1.18M ﹤0.01% 1091
2025
Q2
$12.7M Buy
119,385
+18,423
+18% +$2M ﹤0.01% 1135
2025
Q1
$12.5M Buy
100,962
+59,159
+142% +$7.72M ﹤0.01% 1142
2024
Q4
$5.15M Sell
41,803
-3,026
-7% -$357K ﹤0.01% 1347
2024
Q3
$4.99M Sell
44,829
-3,739
-8% -$410K ﹤0.01% 1330
2024
Q2
$5.18M Sell
48,568
-185,250
-79% -$20.4M ﹤0.01% 1315
2024
Q1
$28.2M Sell
233,818
-1,046,379
-82% -$128M 0.01% 865
2023
Q4
$157M Sell
1,280,197
-388,314
-23% -$48.5M 0.03% 442
2023
Q3
$216M Sell
1,668,511
-199,071
-11% -$26.5M 0.04% 350
2023
Q2
$232M Buy
1,867,582
+11,642
+0.6% +$1.57M 0.04% 359
2023
Q1
$272M Sell
1,855,940
-61,950
-3% -$9.16M 0.05% 321
2022
Q4
$306M Sell
1,917,890
-37,592
-2% -$5.51M 0.06% 294
2022
Q3
$261M Sell
1,955,482
-300,265
-13% -$45.7M 0.06% 302
2022
Q2
$352M Sell
2,255,747
-369,387
-14% -$56.9M 0.07% 245
2022
Q1
$409M Buy
2,625,134
+184,124
+8% +$26.7M 0.07% 253
2021
Q4
$311M Buy
2,441,010
+277,982
+13% +$36.5M 0.05% 329
2021
Q3
$282M Buy
2,163,028
+482,295
+29% +$72.9M 0.05% 362
2021
Q2
$299M Buy
1,680,733
+120,182
+8% +$20.8M 0.05% 347
2021
Q1
$257M Buy
1,560,551
+1,488,368
+2,062% +$245M 0.05% 372
2020
Q4
$11.9M Sell
72,183
-5,496
-7% -$819K ﹤0.01% 1145
2020
Q3
$11.1M Sell
77,679
-11,144
-13% -$1.38M ﹤0.01% 1083
2020
Q2
$9.8M Sell
88,823
-7,163
-7% -$792K ﹤0.01% 1076
2020
Q1
$9.57M Sell
95,986
-76,991
-45% -$9.95M ﹤0.01% 1045
2019
Q4
$25.8M Sell
172,977
-58,661
-25% -$7.98M 0.01% 920
2019
Q3
$29.7M Buy
231,638
+524
+0.2% +$70.2K 0.01% 868
2019
Q2
$32.9M Buy
231,114
+173,676
+302% +$23.3M 0.01% 882
2019
Q1
$8.21M Buy
+57,438
New +$7.49M ﹤0.01% 1255
2018
Q4
Sell
-10,622
Closed -$1.79M 2123
2018
Q3
$1.79M Sell
10,622
-25,421
-71% -$4.37M ﹤0.01% 1730
2018
Q2
$6.21M Sell
36,043
-32,002
-47% -$5.23M ﹤0.01% 1422
2018
Q1
$10.3M Sell
68,045
-1,298
-2% -$190K ﹤0.01% 1266
2017
Q4
$9.34M Buy
69,343
+64,093
+1,221% +$8.89M ﹤0.01% 1292
2017
Q3
$767K Buy
+5,250
New +$794K ﹤0.01% 1958
2016
Q4
Sell
-14,150
Closed -$1.72M 2227
2016
Q3
$1.72M Sell
14,150
-564,662
-98% -$76.1M ﹤0.01% 1686
2016
Q2
$81.8M Sell
578,812
-56,620
-9% -$8.35M 0.02% 532
2016
Q1
$83M Sell
635,432
-18,185
-3% -$2.26M 0.02% 517
2015
Q4
$91.9M Sell
653,617
-146,869
-18% -$20.4M 0.02% 495
2015
Q3
$106M Sell
800,486
-132,577
-14% -$22.8M 0.03% 434
2015
Q2
$164M Sell
933,063
-24,611
-3% -$4.42M 0.04% 359
2015
Q1
$165M Buy
957,674
+243,315
+34% +$41.8M 0.04% 375
2014
Q4
$117M Buy
714,359
+296,900
+71% +$49.3M 0.03% 459
2014
Q3
$67M Buy
417,459
+256,622
+160% +$39.5M 0.02% 617
2014
Q2
$23.6M Buy
160,837
+71,132
+79% +$9.86M 0.01% 977
2014
Q1
$12.4M Sell
89,705
-62,173
-41% -$9.36M ﹤0.01% 1184
2013
Q4
$19.2M Sell
151,878
-289,427
-66% -$29.9M 0.01% 1019
2013
Q3
$40.6M Buy
441,305
+62,850
+17% +$5.07M 0.01% 775
2013
Q2
$26M Buy
+378,455
New +$23.1M 0.01% 885

Other funds holding JAZZ

Wellington Management Group's JAZZ Position: Q1 2026 in Review

Wellington Management Group increased its Jazz Pharmaceuticals (JAZZ) stake by 307% in Q1 2026, buying an estimated $60.4M and bringing the position to 458,014 shares worth $86.6M. The position accounts for 0.02% of the portfolio, ranked #583.

Wellington Management Group first reported a position in JAZZ in Q2 2013 and has held it in 48 quarters since. The position peaked at $409M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Wellington Management Group held 458,014 shares of Jazz Pharmaceuticals worth $86.6M as of Q1 2026.
  • Wellington Management Group bought 345,454 Jazz Pharmaceuticals shares in Q1 2026, an estimated $60.4M.
  • Jazz Pharmaceuticals made up 0.02% of Wellington Management Group's portfolio in Q1 2026, its #583 holding.
  • Wellington Management Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
  • Wellington Management Group's Jazz Pharmaceuticals position peaked at $409M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.